Throughout development,the endocrine f a c t o r s involved i n glucose homeos t a s i s vary i n r e l a t i o n t o age and maturation. The endocrine-metabolic m i l i e u i n u t e r o changes d r a m a t i c a l l y a t b i r t h and then g r a d u a l l y t h r o u g h G F i i E n c y and childhood. The a v a i l a b l e data demonstrate a u n ique response o f t h e developing i n f a n t i n r e g u l a t i n g glucose homeostasis i n both h e a l t h and disease. Hormone values alone, do n o t adequately e x p l a i n the v u l n e r a b i l i t y o f the neonate o r i n f a n t t o hypoglycemia. Additional studies i n v o l v i n g recent advances i n our understanding o f hormone a c t i o n through receptor s i t e s , feed-back mechanisms and enzyme r e g u l a t i o n w i l l be necessary t o extend our understanding o f the basic mechanisms involved.
National I n s t i t u t e s o f Health, Bethesda, MD., USA Throughout development,the endocrine f a c t o r s involved i n glucose homeos t a s i s vary i n r e l a t i o n t o age and maturation. The endocrine-metabolic m i l i e u i n u t e r o changes d r a m a t i c a l l y a t b i r t h and then g r a d u a l l y t h r o u g h G F i i E n c y and childhood. The a v a i l a b l e data demonstrate a u n ique response o f t h e developing i n f a n t i n r e g u l a t i n g glucose homeostasis i n both h e a l t h and disease. Hormone values alone, do n o t adequately e x p l a i n the v u l n e r a b i l i t y o f the neonate o r i n f a n t t o hypoglycemia. Additional studies i n v o l v i n g recent advances i n our understanding o f hormone a c t i o n through receptor s i t e s , feed-back mechanisms and enzyme r e g u l a t i o n w i l l be necessary t o extend our understanding o f the basic mechanisms involved.
I n t h e f e t u s , carbohydrate balance depends upon the maternal supply o f glucose, v i a t h e placenta and, as f a r as i s known, on f e t a l production o f i n s u l i n and c o r t i s o l . L i t t l e data are a v a i l a b l e concerning the i n t e ra c t i o n s o r e f f e c t s o f hypothalamic f a c t o r s o r o t h e r hormones on f e t a l carbohydrate homeostasis. However, almost immediately a f t e r b i r t h , s p e c i f i c , y e t unique responses o f m u l t i p l e endocrine secretions occur. The blood glucose values tend t o be lower i n t h e neonatal p e r i o d than l a t e r i n t h e presence o f normal values f o r c o r t i s o l , low, f o r i n s u l i n , and high, f o r glucagon, hGH, T4 and reverse T3.
The v a r i e t y o f hypoglycemic syndromes i n the neonatal and e a r l y infancy periods e l u c i d a t e some unique aspects o f hormonal s e c r e t i o n and a c t i o n s . Hyperinsulinism, i n u t e r o whether t r a n s i e n t as i n t h e i n f a n t o f the d i a b e t i c mother, v p e e n t due t o malformation o f i s l e t c e l l format i o n and f u n c t i o n , can produce a number o f a f f e c t s before and a f t e r b i r t h . I n t h e primate model i n s u l i n alone has been shown t o induce macrosomia, extramedullary hematopoiesis, lipogenesis and glycogen storage. There are a l l present i n the i n f a n t of the d i a b e t i c mother, b u t r a p i d l y disappear over a s h o r t p e r i o d o f time. I n a d d i t i o n , increased i n s u l i n receptor s i t e s have been demonstrated on t h e monocytes o f cord blood o f i n f a n t s o f d i a b e t i c mothers. However, i n t h e i n f a n t born w i t h an abnormality o f i s l e t c e l l f u n c t i o n o r formation, e.g. nesideoblastosis, the profound hypoglycemia can be l i f e threaten i n g even i n t h e presence o f p i t u i t a r y and adrenal hormonal responses. Some data would suggest t h a t the malformation involves n o t o n l y t h e i n s u l i n producing beta c e l l , b u t t h e alpha, d e l t a and pancreatic polypeptide c e l l s as w e l l and thus a t o t a l paracrine dysfunction occurs which i n t e r f e r e s w i t h glucose homeostasis. Preliminary data on i n f a n t s w i t h p e r s i s t e n t hyperinsulinemia from b i r t h and subsequently t r e a t e d e i t h e r o p e r a t i v e l y o r w i t h diazoxide suggest t h a t increased i n s u l i n receptor s i t e s may p e r s i s t . Thus, the abnormality noted i n hyperi n s u l i n i s m may have f a r reaching e f f e c t s beyond those u s u a l l y a t t r i b ut e d t o i n s u l i n alone.
The syndrome o f congenital hypopitui t a r i s m i s another example o f unique endocrine-glucose i n t e r r e l a t i o n s h i p s i n t h e neonatal period. This syndrome c l e a r l y i n d i c a t e s t h a t the absence o f growth hormone and c o r t i s o l may r e s u l t i n profound, even f a t a l , hypoglycemia i n the f i r s t hours a f t e r b i r t h . Yet, o t h e r i n f a n t s w i t h the same c o n d i t i o n may maintain normoglycemia and l a t e r develop, k e t o t i c hypoglycemia between 1 and 5 years o f age. Hypothalamic f a c t o r s have been found d e f i c i e n t i n some o f these p a t i e n t s leading t o an inadequate feedback mechanism o f carbohydrate homeostasis. K e t o t i c hypoglycemia i s the most prevalent form o f low blood glucose between 1 and 5 years o f age. Some o f these were i n f a n t s who had been hypoglycemic i n the neonatal p e r i o d as SGA babies, o r because of panhypopi t u i t a r i s m o r i s o l a t e d growth hormone deficiency, w h i l e others had no previous evidence o f carbohydrate i n t o l e r a n c e . Fasting ketosis followed by hypoglycemia may r e f l e c t inadequate normal feedback mechanisms which r e g u l a t e hormones responsible f o r glycogenolysis and gluconeogenesis. These abnormal responses disappear beyond age 7 o r 8. Thereafter the c h i 1 d begins t o show normal hormonal -glucose r e l a t i o n s h i p s .
Glucose homeostasis i s t h e r e s u l t o f complex i n t e r a c t i o n s t h a t change profoundly throughout development. T h e i r complex nature r e q u i r e the a p p l i c a t i o n o f r e c e n t l y develop concepts t o understand t h e underlying mechanisms. H.G. HERS
Laboratoire de Chimie Physiologique, U n i v e r s i t e de Louvain, and I n t e r n a t i o n a l I n s t i t u t e o f C e l l u l a r and Molecular Pathology, Brussels, Belgium Glucose occupies a unique p o s i t i o n i n intermediary metabolism f o r two reasons: 1. i t i s t h e substrate o f g l y c o l y s i s which i s t h e o n l y pathway t o produce ATP i n anaerobic l i f e 2. i t i s t h e major and u s u a l l y t h e unique substrate f o r b r a i n metabolism.
The second reason i s by f a r the most important i n t h e human body and one major r o l e o f the l i v e r i s t o maintain a normal l e v e l o f glycaemia.
The c o n t r o l o f t h e l e v e l o f glycaemia by t h e l i v e r involves the storage o f qlucose as slvcosen and the formation o f qlucose from endogenous
The c o n t r o l o f glycogen metabolism i n t h e l i v e r
As explained i n d e t a i l i n a recent review (Hers, Ann. Rev. Biochem., 45, 167-189, 1976) 
the r a t e l i m i t i n g steps o f glycogen synthesis and Eeakdown i n the l i v e r are catalyzed by glycogen synthase and glycogen phosphorylase. Each o f these enzymes e x i s t i n two forms: one a c t i v e a),and t h e o t h e r one i n a c t i v e ( b ) . The a and b forms are interconverLTble through phosphorylation by-kinases-and dgphosphorylation by phosphatases. Glucose i s r e a d i l y d i f f u s a b l e i n s i d e o f t h e l i v e r c e l l .
I t binds t o phosphorylase a which can be considered as t h e glucose receptor o f t h e l i v e r . Theglucose bound phosphorylase a i s r a p i d l y converted t o phosphorylase b by phosphorylase phosphatase. A f i r s t e f f e c t o f glucose i s t o deckase and e v e n t u a l l y t o a r r e s t glycogen degradation i n the l i v e r . Furthermore, phosphorylase a i s a strong i n h i b i t o r o f synthase phosphatase, t h e enzyme t h a t a c t i v a t e s glycogen synthase. Therefore, t h e disappearance o f phosphorylase a as a r e s u l t o f glucose b i n d i n g allows the a c t i v a t i o n o f glycogen synThase and the i n i t i a t i o n of glycogen synthesis. Various i o n i c and hormonal e f f e c t s i n c l u d i n g those o f i n s u l i n appear t o be explained by a primary a c t i o n on the i n a c t i v a t i o n o f phosphorylase. Glucagon causes glycogenolysis by t h e intermediary o f c y c l i c AMP, a c t i v a t i o n o f p r o t e i n kinase, phosphorylase kinase and phosphorylase. Each step o f t h i s glycogenol y t i c pathway has been observed i n hepatocytes incubated i n t h e presence o f t h e hormones. I n contrast, catecholamines and o t h e r agonists i n c l u d i n g vasopressin and angiotensin s t i m u l a t e glycogenolysis by another mechanism, p o s s i b l y i n v o l v i n g a change i n calcium concentrat i o n . I n s u l i n counteracts the e f f e c t o f these glycogenolytic agents by a c t i n g a t various steps o f the glycogenolytic cascade.
The c o n t r o l _of gluconeogenesis and t h e f _ u t i l e cycles F u t i l e c y c l e i s a metabolic interconversion o f which the n e t balance i s t h e consumption o f ATP. Three such cycles e x i s t on the pathway o f g l y c o l y s i s and gluconeogenesis (1) a t the l e v e l o f glucose/ glucose 6-phosphate interconversion ( 2 ) a t the l e v e l o f f r u c t o s e 6-phosphat~/fructose diphosphate interconversion ( 3 ) a t the l e v e l o f pyruvate/phosphoenolpyruvate interconversion. The bestknown mechanism by which glucagon stimulates gluconeogenesis i s the i n a c t i v a t i o n , by phosphorylation, o f pyruvate kinase, preventing f u t i l e r e c y c l i n g between phosphoenolpyruvate and pyruvate. The c o n t r o l o f the r e c y c l i n g between f r u c t o s e 6-phosphate and f r u c t o s e diphosphate i s s t i l l badly understood b u t appears t o be c o n t r o l l e d by glucagon also. Recycling between glucose and glucose 6-phosphate occurs continuously and i s c o n t r o l l e d o n l y by t h e concentration o f substrate: i t plays a major r o l e i n the c o n t r o l o f glucose uptake and glucose output by t h e l i v e r .
THE TRANSPORT OF VITAMIN 0 R. BOUILLON and H. VAN BAELEN Rega I n s t i t u t e , U n i v e r s i t y o f Leuven, Leuven, Be1 g i um Vitamin 0 and i t s hydroxylated metabolites are transported i n the blood, bound t o a t r a n s p o r t p r o t e i n . For t h i s purpose, c a r t i l a g i n o u s f i s h and amphibia use l i p o p r o t e i n s b u t bony f i s h , r e p t i l e s , b i r d s and mammals have a s p e c i f i c vitamin D-binding p r o t e i n , c a l l e d DBP. We have i s o l a t e d DBP from t h e serum o f man, r a t and chick and compared t h e i r c h a r a c t e r i s t i c s .
